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“I love the doctors—they are dears; 
But must they spend such years and years
Investigating such a lot
Of illnesses which no one’s got,
When everybody, young and old,
Is frantic with the common cold?
And I will eat my only hat
If they know anything of that.”
W
hen I first read this little 
poem in The Lancet in 
January 2003 (Heikkinen and 
Jarvinen 2003), it elicited little more 
than a bemused chortle. There are 
few who would deny the paradox that 
for all the medical advances providing 
cures for multitudinous diseases 
afflicting the human condition, 
there remains a large hole in the 
understanding of and treatment for 
the common cold. We know that it 
is caused mainly by rhinoviruses and 
coronaviruses, but that’s about it. 
Having worked on coronaviruses for 
my doctoral thesis, I knew some of the 
many open questions. 
A few months later, however, our 
ignorance concerning these viruses 
took on an urgent relevance when an 
exploding viral pandemic in southern 
China, Hong Kong, Vietnam, Canada, 
and Singapore left the scientific 
community stunned. In March 2003, 
nobody was prepared for the onslaught 
of SARS (severe acute respiratory 
syndrome)—we knew nothing about 
the causative agent for the disease and 
had no idea how to treat it. 
In Singapore, the SARS outbreak 
constituted the most challenging 
medical crisis in decades. Doctors, 
scientists, government officials, 
educators, and even businessmen 
scrambled to contain the epidemic. 
Schools were closed and children 
were ordered to stay at home. 
Business organizations granted 
their employees medical leave, and 
many offices shut down temporarily. 
The bustling commerce and social 
scene in the country all but ground 
to a halt as people were afraid to 
gather in crowded places. Even some 
churches were closed and Sunday 
masses cancelled; those that remained 
opened required the congregation 
to don protective masks at all times. 
Travelling on public buses and trains 
suddenly became an exercise in not 
merely avoiding the rush-hour crowds, 
but in avoiding any crowds at all. 
Trendy shopping centres, cafes, and 
restaurants, once vaunted for packing 
in the throngs, became places to be 
avoided as the forbidding belief quickly 
spread that crowded places were 
hotspots for the transmission of SARS.
At Changi Airport, all in- and out-
bound passengers from Singapore were 
“temperature-printed” (that is, they 
were asked to walk through scanners 
that picked up body temperatures 
above 37.4˚C) in order to curb the 
export and import of SARS. With 
close to 100 medical workers dressed 
in camouflage fatigues, gloves, and 
surgical masks stationed at the gateways 
to the country and ambulances ready 
to whisk away anyone who was sick or 
showed questionable signs of infection, 
the international press labelled the 
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normally bustling airport a “combat 
zone.”
Despite the rampant fear of SARS 
and the frantic measures to contain it, 
not everyone complied with the rules 
and regulations. Schools required 
that students declare the countries 
and places they had visited over the 
weekend or during the mid-semester 
holidays, but there were parents 
who told their children to conceal 
questionable information for fear of 
having to quarantine them at home. 
Violation of quarantine orders by a few 
prompted the Singapore government 
to threaten fines and jail sentences for 
those who failed to comply. Cameras 
were installed in homes to ensure 
that people put under quarantine 
stayed indoors, and those who refused 
had electronic tags strapped around 
their wrists. Such drastic measures—
prompting the International Herald 
Tribute to refer to Singapore as “a 
country with a reputation for dramatic 
approaches to public policy” (Bradsher 
2003)—may have been greeted with 
defiance and frustration at first, but 
the vast majority of the population 
got quickly behind the approach. 
There was to be no letting up on 
the vigilance and precaution. Not 
when it came to SARS. In the three 
months that Singapore was labelled 
as a “SARS country” by the World 
Health Organization (WHO), over 
200 cases of SARS were reported, and 
33 people died. These figures were 
devastating for Singapore, which had 
not witnessed an epidemic of such 
proportions since the 1950s, when 
polio was a major problem. Referring 
to the high standards of medical care 
and the societal measures put in place, 
Dr David Mansoor of WHO said that if 
not even Singapore could contain the 
outbreak, it was going to be very hard 
for other countries to prevent SARS 
from spreading (Chua 2003). 
On the research front, WHO wasted 
no time in assembling a network of 
international laboratories to facilitate 
the identification of the causative 
agent of SARS. On  April 3, 2003, it 
was announced that a new coronavirus 
variant had been isolated from 
patients with SARS in Hong Kong, and 
therefore this virus was hypothesized to 
be the primary cause of the disease.
I remember that day clearly. It 
proved to be a turning point in the 
worldwide effort to contain SARS—
especially for Singapore and countries 
in Asia at large—and it changed the 
course of my scientific career, if not my 
life. On March 8, 2002, I had joined 
the Genome Institute of Singapore 
(GIS)—a new organization funded by 
the quasi-governmental Agency for 
Science, Technology, and Research 
(A*STAR) and headed by Professor 
Edison Liu and Professor Ren Ee 
Chee—to work with Professor Ren 
as a postdoctoral fellow on hepatitis 
B virus (HBV). The study aimed to 
uncover novel therapeutic targets by 
using various technology platforms to 
enhance current treatments available to 
HBV sufferers and carriers. My posting 
at GIS was a refreshing change from 
my previous research experiences in 
animal coronaviruses, as I got to work 
more closely with human diseases and 
genomics. 
When the SARS virus was linked to 
the Coronaviridae (CoV) family, my first 
reaction was one of excitement and 
trepidation. Excitement because I knew 
a lot about these viruses from my PhD 
research, and trepidation because I was 
aware that the virus had been afflicting 
the agricultural industry for years, with 
devastating consequences. Together 
with senior staff from the local 
hospitals, I took part in an emergency 
meeting called by Professor Liu, who 
stated the challenge: we needed to 
identify the new strain of virus and 
to develop an accurate and reliable 
diagnosis for SARS. 
I was to be part of the diagnostic 
team, and work began almost 
immediately. Although we were under a 
great deal of pressure and stress, there 
was also a certain level of excitement 
in the face of a real-life crisis situation. 
The early days were the toughest, as 
we had very little information and 
were more or less groping in the dark. 
Long, exhausting hours took over our 
lives, and on many occasions I felt 
discouraged and frustrated when the 
experiments did not yield anticipated 
results. However, there was no time 
to be despondent and ponder the 
vicissitudes of life as more and more 
people—friends among them—were 
struck down by the disease. All of us felt 
the need to work even harder, as we 
knew we could not afford to fail. The 
key goal was to uncover the complete 
sequence of the virus. 
At the end of April, researchers 
at the Michael Smith Genome 
Sciences Centre in Vancouver, 
British Columbia, Canada, and at the 
National Microbiology Laboratory in 
Winnipeg, Manitoba, Canada, were 
the first to obtain the full sequence 
of SARS–CoV. In the following week, 
the sequencing team at GIS, led by 
Dr Ruan Yijun, obtained five different 
complete sequences (designated “SIN”) 
and compared these with the isolates 
from Canada (TOR2), Hong Kong 
(CUHK-W1 and HKU39849), Hanoi 
(URBANI), Guangzhou (GZ01), and 
Beijing (BJ01, BJ02, BJ03, and BJ04). 
Dr Ruan’s team identified sequence 
variations among the 14 isolates, and 
common variant sequences at four loci 
defined two distinct genotypes of the 
SARS virus, whose signatures could be 
used to trace the sources of infection. 
Shortly after this achievement, GIS 
entered into a collaboration, through 
Exploit Technologies (the commercial 
arm of A*STAR), with Roche 
Diagnostics GmbH to develop a reliable 
diagnostic kit for SARS. The GIS team, 
which involved Prof Ren, Dr Martin 
Hibberd, and myself, aimed to develop 
a clinically reliable polymerase chain 
reaction (PCR) assay for the SARS 
sequence based on Roche’s LightCycler 
system. A one-step reverse transcription 
PCR (RT-PCR) assay was developed for 
specific and highly sensitive detection 
of SARS–CoV RNA from clinical 
samples. Multiple teleconferences were 
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held with our collaborator, Dr Thomas 
Emrich from Roche Diagnostics 
Penzberg, to work out technical details 
before the optimal conditions were 
obtained. After two months of work, 
the kit performed to our satisfaction 
and became available commercially. 
Collaborating with Roche not only 
made a big difference to my ideas and 
my few experiments, but it was also a 
truly enriching experience to work with 
some of the world’s experts in clinical 
diagnostics. 
From my earlier work, I had a good 
understanding of coronaviruses and 
their functional gene products, as 
my previous projects involved the 
study of the proteolytic processing 
of viral products. Data obtained 
from this work were significant for 
further understanding of coronavirus 
replication and pathogenesis, but never 
had I imagined that I would be able 
to use this knowledge in designing the 
SARS–CoV diagnostic kit with Roche.
Beginning in May, the SARS 
pandemic started to retreat, and by 
the end of July, the WHO declared the 
end of the outbreak. The vigilance, 
however, is expected to continue for 
some time, as WHO authorities have 
warned of a possible return of SARS 
during the winter months in the 
Northern Hemisphere. In Singapore, 
temperature monitoring is still in 
place in many organizations, and as 
I was writing this article, news broke 
that another SARS case had been 
discovered here. However, this time 
round, the authorities and the people 
are technically, academically, and 
emotionally much better prepared for 
the challenge. 
The months working on SARS 
opened my mind, as it did my heart, 
about the importance of research and 
of keeping our faith and motivation 
even in the toughest times. Interacting 
with some of the best minds in the 
field strengthened my commitment to 
a scientific vocation. But even more 
importantly, it reminded me of the true 
reasons for and potential of cold-eyed, 
back-breaking scientific exploration. I 
feel truly privileged to have been part 
of the unfolding of a small medical 
revolution. 
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